Study suggests SARS-CoV-2 Omicron variant RBM binding may be weaker than in wild-type
A new study shows that the Omicron variant binds to the ACE2 receptor in a significantly weaker manner than other variants and the wild-type.
Stay updated with breaking news from Sam Hancockdec. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new study shows that the Omicron variant binds to the ACE2 receptor in a significantly weaker manner than other variants and the wild-type.
Researchers have created a tool designed to make as much use of the overwhelming amount of SARS-CoV-2 data as possible.
Researchers have created a model of looking at the spread of COVID-19 that takes both vaccination rates and rates of loss of immunity into account and can be adjusted as factors change.
Researches have been investigating the possibility of using convalescent plasma to help patients recover from COVID-19.
A new study supports the hypothesis that heterologous vaccination can provide an increased immune response against virus infection, supporting several other studies that have indicated similar events.